Zhengbo Song

机构：Zhejiang Cancer Hospital

发表论文 5 篇 · 总被引 22 次 · h-index 3

代表论文

• A first-in-human phase I/II study of GFH375, a highly selective and potent oral KRAS G12D inhibitor in patients with KRAS G12D mutant advanced solid tumors. (2025 · Journal of Clinical Oncology · 被引 14)
• Clinical features and prognostic biomarkers in patients with SMARCA4-mutated non-small cell lung cancer (2024 · Translational Lung Cancer Research · 被引 4)
• Efficacy of immune checkpoint inhibitor rechallenge in initial immunotherapy responders with advanced non-small cell lung cancer: A single-center retrospective study (2024 · Investigational New Drugs · 被引 3)
• Correction: Efficacy and safety analysis of anlotinib in combination with immune checkpoint inhibitors for second-line and subsequent extensive-stage small-cell lung cancer (2024 · Neoplasma · 被引 1)
• [Progress in Tissue Specimens Alternative for the Driver Genes Testing of Non-small Cell Lung Cancer]. (2015 · PubMed)